4/22
Coronavirus Research
Chewing to curb COVID
Chewing to curb COVID
Penn Medicine will conduct a new clinical trial to evaluate the safety and efficacy of a chewing gum designed by School of Dental Medicine researchers to trap SARS-CoV-2 in the saliva.
Who wants government health care and unemployment programs to expand?
Who wants government health care and unemployment programs to expand?
A study by Penn LDI fellows finds that people who felt most at risk from COVID-19 tend to favor expansions, regardless of their political attitudes.
Behind the scenes in the lab and the future of mRNA research
Behind the scenes in the lab and the future of mRNA research
Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab.
Severe COVID-19 increases risk of life-threatening blood clots
Severe COVID-19 increases risk of life-threatening blood clots
A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza.
Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’
Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’
According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks.
Music-making and the flow of aerosols
Music-making and the flow of aerosols
If simply breathing can spread the SARS-CoV-2 virus to others nearby, what about blowing into a tuba? Researchers from the School of Engineering the School of Arts & Sciences used fluid mechanics to study the movement of aerosols generated by musicians.
University of Pennsylvania’s first NFT commemorates mRNA research
University of Pennsylvania’s first NFT commemorates mRNA research
Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn.
Text messaging shows promise in reaching unvaccinated patients
Text messaging shows promise in reaching unvaccinated patients
A Penn study finds that while automated texting did not get more patients to get their vaccinations against COVID-19, it reached roughly the same amount as manned phone calls.
Dan Treglia on the caregivers lost to COVID
Dan Treglia on the caregivers lost to COVID
The associate professor of practice in the School of Arts & Sciences identifies the number of children who have lost parents and caregivers to COVID-19 and how to support them.
Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely
Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely
A team from the University of Pennsylvania analyzed genomic data from global populations, including thousands of ethnically diverse Africans, to identify genetic variants that may be associated with clinical COVID-19 outcomes.
In the News
CBS News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Minnesota Public Radio
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Philadelphia Inquirer
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Boston Globe
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
NPR
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Time
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →